Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosa B Thorolfsdottir

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
JAMA Cardiology|September 11, 2024
On the Road to Disclose the Pathogenesis of Pericarditis-ReplyRosa B Thorolfsdottir, Daniel F Gudbjartsson, Kari Stefansson
Journal of the American College of Cardiology|October 21, 2017
A Missense Variant in PLEC Increases Risk of Atrial FibrillationRosa B Thorolfsdottir, Gardar Sveinbjornsson, Patrick Sulem, et al.
European Heart Journal|March 29, 2018
A rare missense mutation in MYH6 associates with non-syndromic coarctation of the aortaThorsteinn Bjornsson, Rosa B Thorolfsdottir, Gardar Sveinbjornsson, et al.
Journal of the American Heart Association|July 14, 2023
Screening for Rare Coding Variants That Associate With the QTc Interval in IcelandGardar Sveinbjornsson, Bara D Benediktsdottir, Gunnlaugur Sigfusson, et al.
Nature Genetics|July 20, 2021
Distinction between the effects of parental and fetal genomes on fetal growthThorhildur Juliusdottir, Valgerdur Steinthorsdottir, Lilja Stefansdottir, et al.
Nature Communications|October 24, 2019
Sequence variants with large effects on cardiac electrophysiology and diseaseKristjan Norland, Gardar Sveinbjornsson, Rosa B Thorolfsdottir, et al.
Circulation. Genomic and Precision Medicine|October 26, 2018
Variants in NKX2-5 and FLNC Cause Dilated Cardiomyopathy and Sudden Cardiac DeathGardar Sveinbjornsson, Eva F Olafsdottir, Rosa B Thorolfsdottir, et al.
Communications Biology|October 2, 2018
Coding variants in <i>RPL3L</i> and <i>MYZAP</i> increase risk of atrial fibrillationRosa B Thorolfsdottir, Gardar Sveinbjornsson, Patrick Sulem, et al.
Human Molecular Genetics|December 1, 2025
Observational and Mendelian randomization studies of plasma sclerostin levels do not provide evidence of cardiovascular adverse effects of sclerostin inhibitionRosa B Thorolfsdottir, Gardar Sveinbjornsson, Grimur Hjorleifsson Eldjarn, et al.
Nature Communications|March 8, 2018
Genome-wide analysis yields new loci associating with aortic valve stenosisAnna Helgadottir, Gudmar Thorleifsson, Solveig Gretarsdottir, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
JAMA Cardiology|September 11, 2024
On the Road to Disclose the Pathogenesis of Pericarditis-ReplyRosa B Thorolfsdottir, Daniel F Gudbjartsson, Kari Stefansson
Journal of the American College of Cardiology|October 21, 2017
A Missense Variant in PLEC Increases Risk of Atrial FibrillationRosa B Thorolfsdottir, Gardar Sveinbjornsson, Patrick Sulem, et al.
European Heart Journal|March 29, 2018
A rare missense mutation in MYH6 associates with non-syndromic coarctation of the aortaThorsteinn Bjornsson, Rosa B Thorolfsdottir, Gardar Sveinbjornsson, et al.
Journal of the American Heart Association|July 14, 2023
Screening for Rare Coding Variants That Associate With the QTc Interval in IcelandGardar Sveinbjornsson, Bara D Benediktsdottir, Gunnlaugur Sigfusson, et al.
Nature Genetics|July 20, 2021
Distinction between the effects of parental and fetal genomes on fetal growthThorhildur Juliusdottir, Valgerdur Steinthorsdottir, Lilja Stefansdottir, et al.
Nature Communications|October 24, 2019
Sequence variants with large effects on cardiac electrophysiology and diseaseKristjan Norland, Gardar Sveinbjornsson, Rosa B Thorolfsdottir, et al.
Circulation. Genomic and Precision Medicine|October 26, 2018
Variants in NKX2-5 and FLNC Cause Dilated Cardiomyopathy and Sudden Cardiac DeathGardar Sveinbjornsson, Eva F Olafsdottir, Rosa B Thorolfsdottir, et al.
Communications Biology|October 2, 2018
Coding variants in <i>RPL3L</i> and <i>MYZAP</i> increase risk of atrial fibrillationRosa B Thorolfsdottir, Gardar Sveinbjornsson, Patrick Sulem, et al.
Human Molecular Genetics|December 1, 2025
Observational and Mendelian randomization studies of plasma sclerostin levels do not provide evidence of cardiovascular adverse effects of sclerostin inhibitionRosa B Thorolfsdottir, Gardar Sveinbjornsson, Grimur Hjorleifsson Eldjarn, et al.
Nature Communications|March 8, 2018
Genome-wide analysis yields new loci associating with aortic valve stenosisAnna Helgadottir, Gudmar Thorleifsson, Solveig Gretarsdottir, et al.
Pageof 2